Abeona Therapeutics Inc.
ABEO
$5.83
-$0.02-0.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.19M | -17.08M | -20.46M | -5.16M | 108.83M |
| Total Depreciation and Amortization | 833.00K | 869.00K | 1.09M | 888.00K | 768.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.87M | -2.14M | 2.01M | 111.00K | -144.04M |
| Change in Net Operating Assets | -9.01M | -1.46M | -593.00K | -17.03M | 15.65M |
| Cash from Operations | -17.50M | -19.80M | -17.95M | -21.19M | -18.78M |
| Capital Expenditure | -479.00K | -935.00K | -1.15M | -2.52M | -2.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.17M | 5.90M | 10.71M | -62.11M | 158.79M |
| Cash from Investing | 15.69M | 4.96M | 9.55M | -64.63M | 155.89M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.33M | -2.22M | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 3.61M | 5.16M | 10.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | -- | 0.00 | 0.00 | -6.00K |
| Cash from Financing | -3.34M | -2.22M | 3.61M | 5.16M | 10.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.15M | -17.06M | -4.79M | -80.65M | 147.60M |